Skip to main content

Table 2 The difference between AD tumor /AD RBM for treatment with 177 Lu and 90 Y

From: Tumor and red bone marrow dosimetry: comparison of methods for prospective treatment planning in pretargeted radioimmunotherapy

Patient number Ratio tumor/RBM dose Percentage difference
177 Lu 90 Y
7 1.88 2.13 13%
10 5.72 6.54 14%
11 8.84 9.78 11%
12 5.08 7.27 43%
13 4.33 4.33 0%
14 5.26 6.37 21%
15 1.49 2.29 54%
16 0.68 1.06 56%
17 1.46 2.02 39%
18 9.45 8.87 −6%
19 5.11 4.97 −3%
20 0.64 0.99 54%
21 10.91 13.72 26%
  1. A positive difference represents a higher tumor-to-RBM dose ratio in 90Y, and the percentage is calculated compared to the 177Lu ratio. RBM = red bone marrow.